CD274 and cholangiocarcinoma: In the present study, combination treatment consisting of gemcitabine, BiTEs, and T cells was investigated to test our hypothesis that pretreatment of CCA cells with gemcitabine would elevate PD-L1 expression, which resulted in increased T cell accumulation by BiTEs and enhanced cytotoxicity to kill CCA cells.